Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
Journal Title: Üroonkoloji Bülteni - Year 2017, Vol 16, Issue 2
Abstract
Muscle invasive bladder cancer (MIBC) is an aggressive tumor with a high rate of early systemic dissemination. The main treatment for MIBC is still radical cystectomy and lymph node dissection. Survival rates for 5-year are 70-80% for organ-confined disease and 20-30% for extravesical disease. Although surgery provides excellent control for organ-confined bladder cancer, recurrences are common in surgery alone. Therefore, it is important to treat micrometastatic disease with perioperative chemotherapy. Although there are grade 1 evidences for use of cisplatin-based neoadjuvant chemotherapy (NAC), utilization of NAC rates are still very low all over the world. Thus, approaches trying to determine the selection of appropriate patients for NAC were investigated. High-risk groups to benefit from NAC includes palpable mass in the detection under anesthesia before surgery, clinical T3 or T4a disease, hydronephrosis, lymphovascular invasion and aggressive variant histology. Risk adaptive approaches based on clinicopathologic parameters may increase the rate of benefit from NAC until routine usage of molecular markers and methods that can detect micrometastatic disease.
Authors and Affiliations
Elif Atağ, Aziz Karaoğlu, Ömer Küçük
Keywords
Related Articles
- EP ID EP226706
- DOI 10.4274/uob.763
- Views 133
- Downloads 0
Ablation Therapies in Small Renal Masses
Small renal masses are defined as renal neoplasms with the largest diameter less than 4 cm and the incidence of renal malignancies is increased with the widespread use of cross-sectional imaging methods. One of the optio...
A Rare Case Mimicking Collecting System Tumor: Antopol-Goldman Lesion
Antopol-Goldman (AG) lesion is a benign condition characterized by flank pain, hematuria, and radiologically detected filling defect in the renal pelvis. It is clinically important because it is confused with renal paren...
Risk Factors for Adrenal Invasion in Renal Cell Carcinoma
Objective: In this study, we aimed to describe the risk factors associated with adrenal invasion in patients who were diagnosed with renal cell carcinoma (RCC) after radical nephrectomy and identify which risk factors ar...
Significance of Pretreatment Testosterone Levels in Prostate Cancer Risk Groups
Objective: In this report, patients, who had testosterone (TE) level data before prostate needle biopsy and who later underwent radical prostatectomy (RP) due to prostate adenocarcinoma, were evaluated. The TE levels wer...
Intravesical Therapies in Non-muscle Invasive Bladder Tumors
In the European Association of Urology (EAU) 2015 Guidelines for non-muscle invasive bladder tumors, maintenance Bacillus Calmette-Guérin (BCG) therapy is a grade A recommendation. In the intermediate-risk group, re-eval...